Deborah E Citrin

Author PubWeight™ 36.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 2008 10.13
2 Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 2011 9.03
3 Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? Nat Clin Pract Oncol 2006 2.97
4 CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma. Clin Cancer Res 2010 1.92
5 Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A 2012 1.38
6 Clinical biomarkers of angiogenesis inhibition. Cancer Metastasis Rev 2008 0.98
7 Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol 2011 0.96
8 Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation. Stem Cells 2013 0.92
9 Surgical management of melanoma brain metastases in patients treated with immunotherapy. J Neurosurg 2011 0.91
10 Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition. Clin Cancer Res 2011 0.89
11 Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens. Biomark Med 2014 0.86
12 Evaluation of the fullerene compound DF-1 as a radiation protector. Radiat Oncol 2010 0.84
13 Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer 2014 0.81
14 Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation. Cancer 2014 0.80
15 Peptidases released by necrotic cells control CD8+ T cell cross-priming. J Clin Invest 2013 0.79
16 Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens. J Cell Mol Med 2008 0.79
17 Inhibition of radiation-induced skin fibrosis with imatinib. Int J Radiat Biol 2012 0.78
18 MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands. Int J Oncol 2013 0.77
19 Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost. Radiat Oncol 2006 0.77
20 Research highlights. Biomark Med 2009 0.75